“…Some of the previous studies have shown findings on CYP2E1 polymorphism associations with CYP2E1 activities and HCC risk (Hayashi et al, 1991;Ladero et al, 1996;Lucas et al, 1995;Marchand et al, 1999;Watanabe et al, 1994;Yu et al, 1995). However, other previous studies have reported that there was no association between CYP2E1 genetic polymorphisms and CYP2E1 activities (Carriere et al, 1996;Inoue et al, 2000;Powell et al, 1998). In other words, including the findings of this study, the literature have shown contradictory findings on associations of CYP2E1 polymorphisms with CYP2E1 activities and HCC risk, especially rs3813867 polymorphism which is in absolute linkage disequilibrium (LD) (|D'|=1 and r 2 =1) with RsaI polymorphism (CYP2E1*5B) (rs2031920), which is associated with higher transcription, increased enzyme activity, and alcoholic liver disease (Grove et al, 1998;Hayashi et al, 1991;Piao et al, 2003;Tanaka et al, 1997;Tsutsumi et al, 1994).…”